Depression and treatment resistance — the chronification of a low-coordination operating point

Depression is read as the chronification of a low-coordination operating point. A sustained HPA-driven withdrawal lowers coordination below health (acute, reversible); under the plasticity layer the excursion writes a retained structural trace that does not revert — the reversible-to-chronified switch. Antidepressant delayed onset is a consolidation timescale; treatment resistance is the trace's depth. efficacy=0; not medical advice.

The structural atlas placed conditions on the ignition / synchrony axis: autism-T under-ignites, schizophrenia over-ignites, epilepsy over-synchronises. Depression sits lower on the same coupling axis and on the new temporal axis the plasticity layer opened, and it is the first disorder to use that layer rather than build it. The handle is the engine's own HPA / stress axis (the M18 cortisol cascade and the M17 valence geometry, where cortisol sits on the withdrawal pole), mapped — with no new constant — to a sustained withdrawal bias through the same coupling map the schizophrenia and epilepsy modules use. Four sign-only results follow, all holding over a rate sweep. A sustained withdrawal lowers the global order parameter below health — the acute, reactive depressed operating point, fully reversible on the static substrate. With plasticity the same excursion writes a retained structural trace that does not revert when the stressor lifts: the reversible→chronified switch, now driven by the HPA handle, deepening with exposure. Antidepressant delayed onset is the slow, cumulative accumulation of restoring structural movement — a consolidation timescale, not a pharmacokinetic delay. And treatment resistance is the depth of the chronified trace: at a fixed restoring budget a deeper trace is proportionally less reachable. The module imports the plasticity layer rather than re-deriving it, adds no tuned constant, and with the rate and stress off reproduces the frozen engine bit-for-bit. efficacy = 0; not medical advice; the hard problem stays open.

Depression on the coupling axis — and the temporal axis E0 opened

Every disorder in the atlas so far has been a fault on the ignition / synchrony axis, read off a static operating point. Depression does not fit there. Its core electrophysiological signature is, in direction, a reduction in large-scale functional coordination — a hypo-coupled state, not an over-ignited or over-synchronised one — and its defining clinical feature is not a momentary state at all but a state that persists: a low mood that has stopped lifting. Those two facts place depression on two axes at once: the lower part of the coupling axis, and the temporal axis the plasticity layer opened. That is why depression is the first disorder built on top of E0 rather than alongside it: it imports the plasticity layer (the reusable PlasticConnectome) and drives it; it does not re-derive the rule.

The HPA handle: chronic stress as a withdrawal bias (grounded, not invented)

The driver is not a free knob. The engine already emerged the stress axis. The global-state layer places cortisol on the avoid / withdrawal pole of the valence axis (valence is approach[dopamine] minus avoid[cortisol]); the interoceptive layer emerges the HPA cortisol cascade — the PVN/SIM1 hub through ACTH to cortisol, with the cortisol peak landing in the cited 15–40 minute window and glucocorticoid negative feedback in place. Chronic HPA drive — a sustained, dysregulated stress signal — is mapped to a sustained withdrawal bias b < 0, which lowers the effective ephaptic coupling exactly as an inhibitory bias does in the schizophrenia and epilepsy maps, k = κ/(1+|b|). Only the sign of that mapping is asserted — chronic stress → withdrawal → hypo-coordination, the direction the M17 valence geometry already fixes; the magnitude of the stress-to-bias gain is [O] (representative), and every sign below is required to hold over a sweep. The HPA kinetics themselves are cited from M18. No new constant enters.

The acute depressed operating point (D1)

Start with the static substrate, no plasticity. Apply the sustained withdrawal (chronic-stress) bias and read the global order parameter. It sits below health: every withdrawal level lowers coordination beneath the healthy anchor (R = 0.390), and a deeper withdrawal lowers it further — a severe withdrawal reaches R ≈ 0.331, well under a mild one. This is the acute, reactive depressed operating point: a hypo-coordinated state, the mechanistic direction of the reduced large-scale connectivity reported in depression. On this static substrate the excursion is fully reversible — remove the stressor and coordination returns. What turns a reactive dip into a chronic illness is the next layer.

Chronification: the reversible→chronified switch on the stress handle (D2)

This is the distinguishing result, and it is the plasticity layer's reversible→chronified switch driven by the HPA handle. Run the same sustained withdrawal, now under plasticity, then remove the stressor. Without plasticity (η = 0) the excursion reverts exactly to baseline — a reactive low mood that lifts when the stressor ends. With plasticity (η > 0) the same excursion leaves a retained structural trace that does not revert when the stressor is removed — the structural substrate of chronic depression — and that trace deepens monotonically with exposure (∥ΔW∥ grows 0.075 → 0.151 → 0.227 → 0.338 as the stress is sustained longer), a kindling-direction sign that holds across the rate sweep. Two cautions are part of the result. First, the robust, sign-stable signal is the retained structural trace ∥ΔW∥; the post-removal coordination R is not asserted to sit below baseline (phase-correlation Hebb consolidates the surviving in-phase structure, so R can tick up) — it is reported, not claimed. The persistent object is the trace. Second, the Axis-A firewall: a retained structural trace is a mechanism boundary, not a claim about the felt quality of chronic low mood (consciousness_claim = 0; the hard problem stays open).

Antidepressant delayed onset as a consolidation timescale (D3)

Antidepressants characteristically take weeks to reach clinical effect — a delay classically tied to slow downstream / plasticity changes rather than the immediate monoamine shift. The layer reproduces that delay as a timescale, not a pharmacokinetic lag. Build the chronified substrate, then apply a coordination-restoring (antidepressant-class) push. The restoring structural movement ∥Wk−Wdep accumulates monotonically over epochs and is small after a single epoch (0.018 after one, 0.138 after eight): the effect builds over a consolidation timescale, not instantly. Its direction is therapeutic — coordination R after the full course exceeds the chronified R — and that sign holds over a rate×strength sweep. It is a direction and a timescale, not a dose and not an efficacy: efficacy = 0.

Treatment resistance is the depth of the trace (D4) — and the firewall

Treatment-resistant depression has the cleanest structural reading of all. Resistance is the depth of the chronified trace. At a fixed restoring budget, the fraction of the depressive structural trace an antidepressant-class push neutralises decreases as the trace deepens: a deeper, longer-consolidated chronification is proportionally less reachable at the same budget, leaving a larger residual — the same fixed budget that nearly clears a shallow trace clears only a fraction of a deep one. The ordering holds across a rate×budget sweep. This is the mechanism-level picture of why a longer, deeper depression is harder to move at fixed effort.

It must be said exactly what this chapter is and is not. Every quantity is an in-silico coupling state, not a clinical measure, a diagnosis, or a prescription. The model asserts mechanism directions — a sustained HPA-driven withdrawal lowers coordination; with plasticity it chronifies; restoration is slow and depth-limited — and nothing about which depression any individual has, whether any drug treats theirs, or that anyone should change a treatment. medium_efficacy_tested = 0 everywhere; real depression is heterogeneous (melancholic, atypical, psychotic, peripartum, seasonal, bipolar, with monoaminergic, HPA, inflammatory, circadian and psychosocial contributors) and that heterogeneity is locked; a retained structural trace is a mechanism boundary, not a claim about the felt quality of depression (Axis-A firewall — consciousness_claim = 0, the hard problem of experience stays open). Bipolar depression, which adds episode switching, needs the state-switching layer (E2) and the two poles that follow in §28–§29; addiction needs sensitisation and remains owed. This is not medical advice, not a diagnosis, not a treatment protocol, and not a cure. efficacy = 0.